Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Wednesday, June 21 • 2:00pm - 3:00pm
#357: Biosimilars and Generics: Access Versus Innovation

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: CME 1.00; IACET 1.00; RN 1.00

This panel will review the balance between expediting generics to market for pricing balance based on competition and the need for the innovation of new drugs (e.g., EpiPen pricing and competitors).

Learning Objectives

Recognize the need for continued innovation with the need to expedite approvals for generics and biosimilars.

Chair

Kurt R. Karst, JD

Speaker

Panelist
Christine Simmon, JD

Panelist
Richard A. Bankowitz



Moderators
KK

Kurt Karst

Director, Prescription Drugs and Biologics, Corporate Transactions, Enforcement, Hyman, Phelps & McNamara, PC
Kurt R. Karst provides regulatory counsel to pharmaceutical manufacturers on Hatch-Waxman patent and exclusivity, drug development, pediatric testing, and orphan drugs, including lifecycle management, approval, post-marketing, and exclusivity issues. He is co-founder and primary... Read More →

Speakers
avatar for Richard Bankowitz

Richard Bankowitz

Executive Vice President for Clinical Affairs, America's Health Insurance Plans (AHIP)
Dr. Richard A. Bankowitz is Executive Vice President for Clinical Affairs at America’s Health Insurance Plans (AHIP). In this role, he works closely with the clinical leaders of AHIP’s member plans to promote high-value health care for consumers. A board-certified internist a... Read More →
KK

Kurt Karst

Director, Prescription Drugs and Biologics, Corporate Transactions, Enforcement, Hyman, Phelps & McNamara, PC
Kurt R. Karst provides regulatory counsel to pharmaceutical manufacturers on Hatch-Waxman patent and exclusivity, drug development, pediatric testing, and orphan drugs, including lifecycle management, approval, post-marketing, and exclusivity issues. He is co-founder and primary... Read More →
avatar for Christine Simmon

Christine Simmon

Senior Vice President, Policy and Strategic Alliances, Association for Accessible Medicines (AAM)
Christine Simmon joined the Association for Accessible Medicines in 2012 as Senior Vice President of Policy & Strategic Alliances, and was named Executive Director of AAM’s Biosimilars Council in 2015. Christine had served as Vice President of Policy, Public Affairs & Developme... Read More →


Wednesday June 21, 2017 2:00pm - 3:00pm
S405b McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616